SCHEMBL3484563

SCHEMBL3484563

CC(c1ccc(C(=O)O)cc1)C(CO)CCc1ccc(C(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
ALDH1A1 P00352 2/20 0.43
RARB P10826 6/20 0.43
ANPEP P15144 2/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
RARA P10276 1/20 0.41
MAPT P10636 1/20 0.41
MTOR P42345 1/20 0.41
GRIN2D O15399 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ENPEP Q07075 1/20 0.40
FOLH1 Q04609 1/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485090 0.88 CYP4A11 (0.39) RXRARXRBALDH1A1RARBMAPT
SCHEMBL2655029 0.79 ALDH1A1 (0.50) RXRARXRBALDH1A1RARBKMT2A
SCHEMBL3484853 0.78 RXRA (0.43) RXRARXRBALDH1A1RARBANPEP
SCHEMBL104594 0.77 GRIN2D (0.57) RXRARXRBALDH1A1RARBKMT2A
SCHEMBL2160396 0.75 ALDH1A1 (0.48) ALDH1A1RARBANPEPKMT2AMEN1
SCHEMBL10629555 0.75 RXRA (0.57) RXRARXRBALDH1A1RARBKMT2A
SCHEMBL31192242 0.74 TSHR (0.60) RXRARXRBALDH1A1ANPEPKMT2A
SCHEMBL825507 0.74 ALDH1A1 (0.52) RXRARXRBALDH1A1RARBANPEP
SCHEMBL14720935 0.74 ALDH1A1 (0.52) RXRARXRBALDH1A1RARBKMT2A
SCHEMBL13243743 0.73 KMT2A (0.54) RXRARXRBKMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609727-B2 Dicarboxylic acid derivatives and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-17 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 RXRA 501/4885RXRB 700/4885ALDH1A1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.